Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen

Kudva, G.C.; Chandy, M.; Raghupathy, P.; Dennison, D.; Srivastava, A.; Bhushan, V.; Singh, R.

Indian Journal of Cancer 31(2): 78-85

1994


ISSN/ISBN: 0019-509X
PMID: 7927453
Document Number: 436746
Thirty-eight children with acute lymphoblastic leukaemia were treated with the BFM regimen. Thirty-six (94.7%) achieved complete remission (CR). Twenty 58.8%) of 34 evaluable patients are in continuous complete remission (CCR) at a median follow-up of 33 (range 19-81) months. Long-term disease-free survival was better in the 2-9 years age group (83%) when compared to the 10-14 years group (43%) (P < .05).

Document emailed within 1 workday
Secure & encrypted payments